Sentences with phrase «imatinib mesylate in»
Phase II, open - label, single - arm trial of imatinib mesylate in patients with metastatic melanoma harboring c - Kit mutation or amplification.
http://www.cancernetwork.com/ Not exact matches
[12] It was marketed in 2001 by Novartis as imatinib mesylate (Gleevec in the US, Glivec in Europe).